City

Philadelphia (1)

Saskatoon (1)

Seattle (1)

Condition

Ovarian Follicle (2)

Follicle Count (1)

Follicle Development (1)

Follicle Size (1)

Oral Contraceptive (1)

Overall Status

Completed (2)

Sign in for free

Phase

n/a (1)

phase 1 (1)

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc. (1)

University of Saskatchewan (1)

Collaborator

Canadian Institutes of Health Research (CIHR) (1)

Intervention

28-day drospirenone oral contraceptive (1)

28-day levonorgestrel oral contraceptive (1)

desogestrel/ethinyl estradiol and ethinyl estradiol (1)

letrozole (1)

marvelon (1)

nuvaring (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

ovarian follicle

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Follicle Development, Ovarian Follicle, Follicle Count Trial in Philadelphia, Seattle (Desogestrel/ethinyl estradiol and ethinyl

Completed

Follicle Development
+4 more

Desogestrel/ethinyl estradiol and ethinyl estradiol
+2 more

Philadelphia, Pennsylvania
+1 more

Dec 1, 2021

Ovarian Follicle Trial in Saskatoon (Marvelon, Nuvaring, Letrozole)

Completed

Ovarian Follicle

Marvelon
+2 more

Saskatoon, Saskatchewan, Canada

Royal University Hospital

Apr 20, 2010